许培扬博客分享 http://blog.sciencenet.cn/u/xupeiyang 跟踪国际前沿 服务国内科研

博文

武汉冠状病毒 2020年1月14日收入美国PUBMED数据库 最新文献分析报告

已有 777 次阅读 2020-2-8 17:16 |个人分类:信息分析|系统分类:科研笔记




新型冠状病毒肺炎   正式命名

https://mp.weixin.qq.com/s?__biz=MzI3NDI5MjI4OQ==&mid=2247539188&idx=1&sn=097234336e1f579834fa3b79b25c0f16&chksm=eb1452dadc63dbccc4a0e80670ca2ac7aabc638e6cc066152d0f5edad42af0bdacdc27bc48f8&mpshare=1&scene=1&srcid=&sharer_sharetime=1581149517136&sharer_shareid=1a2398dba06461eb2c4d1de07dfcff98&key=daf25faafa4089aaf210e875d25da6c0d37c016f6316a0857f04dc7542a0103d8d92455c86676b441ab457a64b6199f6d34cfe439702d1665e3e8ecebc23cf556742a280558226d6465f157efe56f31e&ascene=1&uin=MTE5OTA3MTYyNg%3D%3D&devicetype=Windows+10&version=6208006f&lang=zh_CN&exportkey=AdkZZx0q2X4LveiJ7j4qEoU%3D&pass_ticket=q2AuRHqtJhzDH1xmVDYlY33QtZEmD2fdOMNzKc77nQuZY6YP93riBANmT5eC38wl

https://www.ncbi.nlm.nih.gov/mesh/?term=Novel+coronavirus+pneumonia

https://www.ncbi.nlm.nih.gov/mesh/?term=Novel+coronavirus+pneumonia

https://www.ncbi.nlm.nih.gov/mesh/2023153

最新文献分析

http://sys.pubmedplus.cn/

年份年份趋势图

记录数

占%

 01.2020     27 17.308%

 02.2019     3 1.923%

 03.2018     2 1.282%

 04.2017     6 3.846%

 05.2016     6 3.846%

 06.2015     10 6.410%

 07.2014     11 7.051%

 08.2013     11 7.051%

 09.2012     7 4.487%

 10.2011     7 4.487%

正在加载中...

期刊期刊分区中科院期刊分区

记录数

占%

 01.j virol     7 4.487%

 02.j infect dis     5 3.205%

 03.j med virol     5 3.205%

 04.lancet     5 3.205%

 05.mbio     5 3.205%

 06.n engl j med     5 3.205%

 07.zhonghua jie he he hu xi za zhi     5 3.205%

 08.biochem biophys res commun     3 1.923%

 09.curr opin pulm med     3 1.923%

 10.plos one     3 1.923%

正在加载中...

国家国家分布图

记录数

占%

 01.中国香港     21 13.462%

 02.美国     15 9.615%

 03.中国大陆     9 5.769%

 04.沙特阿拉伯     9 5.769%

 05.英国     6 3.846%

 06.加拿大     5 3.205%

 07.印度     5 3.205%

 08.新加坡     3 1.923%

 09.澳大利亚     3 1.923%

 10.荷兰     3 1.923%

查看更多

大陆城市境外城市

记录数

占%

 01.中国香港     21 13.462%

 02.沙特阿拉伯利雅得     9 5.769%

 03.delhi     3 1.923%

 04.印度新德里     3 1.923%

 05.新加坡市     3 1.923%

 06.澳大利亚布里斯班     3 1.923%

 07.美国亚特兰大     3 1.923%

 08.美国北卡罗来纳州教堂山镇     3 1.923%

 09.加拿大多伦多     2 1.282%

 10.加拿大温尼伯     2 1.282%

 11.墨西哥城     2 1.282%

 12.美国贝塞斯达     2 1.282%

 13.英国伦敦     2 1.282%

 14.荷兰鹿特丹     2 1.282%

 15.amman     1 0.641%

 16.benares     1 0.641%

 17.durango     1 0.641%

 18.ecatepec     1 0.641%

 19.guadalajara.mexico     1 0.641%

 20.la salud     1 0.641%

 21.oiso     1 0.641%

 22.pomezia     1 0.641%

 23.saint-pierre-des-corps     1 0.641%

 24.sankt gallen     1 0.641%

 25.veracruz     1 0.641%

 26.winchester.uk     1 0.641%

 27.中国台北     1 0.641%

 28.丹麦奥胡斯     1 0.641%

 29.南非开普敦     1 0.641%

 30.希腊雅典     1 0.641%

 31.德国波恩     1 0.641%

 32.意大利罗马     1 0.641%

 33.日本仙台     1 0.641%

 34.沙特阿拉伯吉达市     1 0.641%

 35.法国巴黎     1 0.641%

 36.波兰克拉科夫     1 0.641%

 37.美国佛罗里达州盖恩斯维尔     1 0.641%

 38.美国哥伦布     1 0.641%

 39.美国坦帕1     1 0.641%

 40.美国奥罗拉     1 0.641%

 41.美国巴的摩尔     1 0.641%

 42.美国旧金山     1 0.641%

 43.美国波士顿     1 0.641%

 44.英国爱丁堡     1 0.641%

 45.英国牛津     1 0.641%

 46.荷兰乌得勒支     1 0.641%

 47.西班牙巴塞罗那     1 0.641%

 48.西班牙马德里     1 0.641%

 49.阿根廷布宜诺斯艾利斯     1 0.641%

大陆作者作者与主题词全部作者作者邮件

记录数

占%

 01.Yuen KY     15 9.615%

 02.Chan KH     9 5.769%

 03.Lau SK     9 5.769%

 04.Woo PC     9 5.769%

 05.Tsoi HW     6 3.846%

 06.Baric RS     5 3.205%

 07.Chan JF     5 3.205%

 08.Cheng VC     5 3.205%

 09.Guan Y     5 3.205%

 10.Li X     5 3.205%

正在加载中...

大陆机构第一作者机构合著机构境外机构

记录数

占%

 01.beijing institute of microbiology and epidemiology     1 0.641%

 02.tuen mun hospital     1 0.641%

 03.中国疾病预防控制中心(中国预防医学科学院)     1 0.641%

 04.中山大学校本部     1 0.641%

 05.北京科技大学     1 0.641%

 06.广东省疾病预防控制中心     1 0.641%

 07.武汉大学校本部     1 0.641%

 08.第四军医大学唐都医院     1 0.641%

主题词主题词搭配主题词与主题词

记录数

占%

 01.severe acute respiratory syndrome     40 25.641%

 02.sars virus     32 20.513%

 03.coronavirus     24 15.385%

 04.coronavirus infections     24 15.385%

 05.phylogeny     14 8.974%

 06.disease outbreaks     13 8.333%

 07.pneumonia, viral     13 8.333%

 08.reverse transcriptase polymerase chain reaction     13 8.333%

 09.middle east respiratory syndrome coronavirus     11 7.051%

 10.communicable diseases, emerging     9 5.769%

正在加载中...

Substance化学药中药

记录数

占%

 01.nucleocapsid proteins     9 5.769%

 02.rna, viral     8 5.128%

 03.antiviral agents     7 4.487%

 04.viral proteins     7 4.487%

 05.recombinant proteins     6 3.846%

 06.spike glycoprotein, coronavirus     6 3.846%

 07.antibodies, viral     5 3.205%

 08.dna, viral     5 3.205%

 09.membrane glycoproteins     5 3.205%

 10.viral envelope proteins     5 3.205%

 11.nucleocapsid protein, coronavirus     4 2.564%

 12.cysteine endopeptidases     3 1.923%

 13.dna primers     3 1.923%

 14.ribavirin     3 1.923%

 15.viral matrix proteins     3 1.923%

 16.viral vaccines     3 1.923%

 17.3c-like protease, sars coronavirus     2 1.282%

 18.anti-bacterial agents     2 1.282%

 19.interferon type i     2 1.282%

 20.interferon-alpha     2 1.282%

 21.jnk mitogen-activated protein kinases     2 1.282%

 22.m protein, coronavirus     2 1.282%

 23.rna replicase     2 1.282%

 24.steroids     2 1.282%

 25.transcription factor ap-1     2 1.282%

 26.viral nonstructural proteins     2 1.282%

 27.3c-like proteinase, coronavirus     1 0.641%

 28.actins     1 0.641%

 29.adjuvants, immunologic     1 0.641%

 30.adrenal cortex hormones     1 0.641%

 31.adrenergic beta-agonists     1 0.641%

 32.alanine transaminase     1 0.641%

 33.angiotensin converting enzyme 2     1 0.641%

 34.anti-inflammatory agents     1 0.641%

 35.antibodies, neutralizing     1 0.641%

 36.antigens, cd     1 0.641%

 37.aspartate aminotransferases     1 0.641%

 38.benzyloxycarbonyl-aspartyl(ome)-isoleucyl-prolyl-aspartyl(ome) fluoromethylketone     1 0.641%

 39.beta-galactosidase     1 0.641%

 40.bronchodilator agents     1 0.641%

 41.bst2 protein, human     1 0.641%

 42.budesonide     1 0.641%

 43.capsid proteins     1 0.641%

 44.caspase 3     1 0.641%

 45.caspases     1 0.641%

 46.ccl2 protein, human     1 0.641%

 47.cell adhesion molecules     1 0.641%

 48.chemokine ccl2     1 0.641%

 49.chemokines     1 0.641%

 50.clec4m protein, human     1 0.641%

疾病症状治疗方法物种解剖食品

记录数

占%

 01.肺炎     104 66.667%

 02.呼吸道疾病     68 43.590%

 03.呼吸道感染     67 42.949%

 04.感染     67 42.949%

 05.病毒性疾病     67 42.949%

 06.严重急性呼吸综合征     65 41.667%

 07.冠状病毒感染     58 37.179%

 08.rna病毒感染     57 36.538%

 09.冠状病毒科感染     56 35.897%

 10.尼多病毒目感染     56 35.897%

 11.细菌感染与真菌病     25 16.026%

 12.肺疾病     24 15.385%

 13.传染病     17 10.897%

 14.病毒性肺炎     16 10.256%

 15.人类流感     15 9.615%

 16.成人呼吸窘迫综合征     14 8.974%

 17.咳嗽     13 8.333%

 18.扭伤与劳损     13 8.333%

 19.新生儿呼吸窘迫综合征     13 8.333%

 20.新出现传染病     12 7.692%

 21.动物疾病     9 5.769%

 22.呼吸功能不全     8 5.128%

 23.肾功能不全     8 5.128%

 24.交叉感染     6 3.846%

 25.副粘病毒科感染     6 3.846%

 26.呼吸困难     6 3.846%

 27.呼吸障碍     6 3.846%

 28.细支气管炎     6 3.846%

 29.创伤和损伤     5 3.205%

 30.动物疾病模型     5 3.205%

 31.动物传染病     4 2.564%

 32.淋巴细胞减少     4 2.564%

 33.社区获得性感染     4 2.564%

 34.单分子负链rna病毒感染     3 1.923%

 35.正粘病毒科感染     3 1.923%

 36.细菌性肺炎     3 1.923%

 37.细菌感染     3 1.923%

 38.血小板减少     3 1.923%

 39.免疫系统疾病     2 1.282%

 40.免疫缺陷综合征     2 1.282%

 41.女性泌尿生殖器疾病和妊娠并发症     2 1.282%

 42.寄生虫病     2 1.282%

 43.寻常狼疮     2 1.282%

 44.心肌炎     2 1.282%

 45.感冒     2 1.282%

 46.支气管炎     2 1.282%

 47.支气管肺炎     2 1.282%

 48.癌,肿瘤     2 1.282%

 49.白细胞减少     2 1.282%

 50.禽流感     2 1.282%

科室学科

记录数

占%

 01.department of microbiology     19 12.179%

 02.department of medicine     7 4.487%

 03.department of microbiology and immunology     5 3.205%

 04.school of medicine     5 3.205%

 05.department of epidemiology     4 2.564%

 06.department of laboratory medicine     3 1.923%

 07.department of respiratory and critical care medicine     3 1.923%

 08.division of intramural research     3 1.923%

 09.global center for mass gatherings medicine     3 1.923%

 10.laboratory of virology     3 1.923%




http://blog.sciencenet.cn/blog-280034-1217609.html

上一篇:新型冠状病毒科研动态与进展
下一篇:抗病毒药物瑞德西韦(remdesivir)国际研究动态与进展

0

该博文允许注册用户评论 请点击登录 评论 (0 个评论)

数据加载中...

Archiver|手机版|科学网 ( 京ICP备07017567号-12 )

GMT+8, 2020-3-28 17:52

Powered by ScienceNet.cn

Copyright © 2007- 中国科学报社

返回顶部